Amivantamab in egfr exon 20 insertion- mutated non-small-cell lung cancer progressing on platinum chemotherapy: Initial results from the chrysalis phase i study

Park, K., Haura, E. B., Leighl, N. B., Mitchell, P., Shu, C. A., Girard, N., Viteri, S., Han, J.-Y., Kim, S.-W., Lee, C. K., Sabari, J. K., Spira, A. I., Yang, T.-Y., Kim, D.-W., Lee, K. H., Sanborn, R. E., Trigo, J., Goto, K., Lee, J.-S., … Cho, B. C. (2021). Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study. Journal of Clinical Oncology, 39(30), 3391–3402. https://doi.org/10.1200/jco.21.00662
Authors:
Keunchil Park
Eric B. Haura
Natasha B. Leighl
Paul Mitchell
Catherine A. Shu
Nicolas Girard
Santiago Viteri
Ji-Youn Han
Sang-We Kim
Chee Khoon Lee
Joshua K. Sabari
Alexander I. Spira
Tsung-Ying Yang
Dong-Wan Kim
Ki Hyeong Lee
Rachel E. Sanborn
Jose Trigo
Koichi Goto
Jong-Seok Lee
James Chih-Hsin Yang
Ramaswamy Govindan
Joshua M. Bauml
Pilar Garrido
Matthew G. Krebs
Karen L. Reckamp
John Xie
Joshua C. Curtin
Nahor Haddish-Berhane
Amy Roshak
Dawn Millington
Patricia Lorenzini
Meena Thayu
Roland E. Knoblauch
Byoung Chul Cho
Affiliated Authors:
Catherine A. Shu
Columbia Affiliation:
elink
Publication Type:
Article
Unique ID:
10.1200/JCO.21.00662
PMID:
34339292
DOI:
10.1200/JCO.21.00662
Journal:
Journal of Clinical Oncology
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View Web of Science Record

Record Created: